Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lexicon Pharmaceuticals
Lexicon Pharmaceuticals
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Fri, 01/18/19 - 10:26 am
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
Zynquista
FDA
advisory panels
sotagliflozin
Sanofi/Lexicon’s sotagliflozin filed in US and EU for type 1 diabetes
Pharmaforum
Fri, 03/30/18 - 06:02 pm
Sanofi
Lexicon Pharmaceuticals
type 1 diabetes
sotagliflozin
3 Fastest-Growing Diabetes Stocks of 2018 -- According to Wall Street
Motley Fool
Sun, 01/21/18 - 10:47 am
diabetes
Senseonics
Lexicon Pharmaceuticals
MannKind
First Oral Drug for Type 1 Diabetes Could be Available in 2018
Xtalks
Sat, 09/16/17 - 11:54 am
type 1 diabetes
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
With an eye on the FDA, Lexicon and Sanofi line up more positive data on diabetes drug
Endpoints
Tue, 08/15/17 - 10:49 am
FDA
Lexicon Pharmaceuticals
Sanofi
type 1 diabetes
sotagliflozin
EMA Backs Eight New Medicines, Turns Down Drugs From Nektar & Vanda
RAPS.org
Sat, 07/22/17 - 12:23 pm
EMA
Europe
Pfizer
Bavencio
Novartis
Rydapt
Lexicon Pharmaceuticals
Xermelo
Vanda
Fanaptum
Nektar
Onzeald
Daiichi Sankyo
3 Top-Performing Biotech Stocks This Week
Motley Fool
Fri, 06/16/17 - 09:51 am
biotech
Kite Pharma
KTE-C19
Bluebird Bio
CAR-T
Lexicon Pharmaceuticals
Lexicon Pharma Goes Three For Three With Sotagliflozin Data
Seeking Alpha
Tue, 06/13/17 - 12:06 pm
Lexicon Pharmaceuticals
sotagliflozin
type 1 diabetes
Sanofi
Lexicon diabetes pill hits endpoint in another phase 3, teeing up regulatory filings by partner Sanofi
Fierce Biotech
Fri, 06/9/17 - 11:02 am
Lexicon Pharmaceuticals
diabetes
clinical trials
sotagliflozin
Sanofi
3 Tremendously Promising Diabetes Drugs Potentially on the Way
Motley Fool
Sun, 03/26/17 - 12:02 pm
diabetes
ertugliflozin
Merck
Pfizer
sotagliflozin
Sanofi
Lexicon Pharmaceuticals
semaglutide
Novo Nordisk
FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug
Yahoo/Reuters
Wed, 03/1/17 - 09:57 am
FDA
Lexicon Pharmaceuticals
carcinoid syndrome
Xermelo
Key FDA Decision And Trial Dates In February
Seeking Alpha
Mon, 01/30/17 - 11:03 pm
FDA
Amgen
Valeant Pharmaceuticals
Amphastar
Egalet
Lexicon Pharmaceuticals
Amicus Therapeutics
Axovant
Lexicon developing type 1 diabetes treatment with Sanofi
Medical Marketing and Media
Mon, 01/23/17 - 11:17 am
Lexicon Pharmaceuticals
Sanofi
drug development
type 1 diabetes
Lexicon's Phase 2 Diabetes Study Looks Good
Investopedia
Wed, 10/26/16 - 08:49 am
Lexicon Pharmaceuticals
sotagliflozin
type 1 diabetes
diabetes
4 Key BioPharma Movers in the Past Week
24/7 Wall St
Sun, 09/11/16 - 10:19 pm
Retrophin
Evoke Pharma
Celgene
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals reports first-quarter loss, misses expectations
Yahoo/AP
Tue, 05/3/16 - 10:19 am
Lexicon Pharmaceuticals
earnings
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Incyte
Myriad
Cara Therapeutics
Sucampo
ZS Pharma
Concert Pharmaceuticals
The Medicines Company
Lexicon Pharmaceuticals
Exelixis
Anacor
4 New Big FDA Decisions Expected in September
24/7 Wall St
Sat, 09/5/15 - 11:01 am
FDA
Tetraphase
VTI208
Vital Therapies
Conatus Pharmaceuticals
Lexicon Pharmaceuticals
telotristat
3 Biotech Stocks Bucking the Stock Market Crash
Motley Fool
Sat, 08/29/15 - 09:01 am
biotech
Lexicon Pharmaceuticals
La Jolla Pharmaceutical
Acorda Therapeutics
Can Lexicon Pharmaceuticals Make Any Progress In Diabetes On Safety?
Seeking Alpha
Tue, 06/9/15 - 09:35 am
Lexicon Pharmaceuticals
diabetes
sotagliflozin
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »